Skip to contentM
Medtronic plc
M
MDTMedtronic plc Q2 2025 · 10-Q
Revenue$8.40B$8.40B+5.2% vs Q2 2024 Net Income$1.27B$1.27B+39.7% vs Q2 2024 EPS Diluted$0.99$0.99+45.6% vs Q2 2024 Operating Income$1,595,000,000+19.0% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medtronic plc · CIK 1613103 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$554,000,000+177.0% Margins · derivedOperating margin19.0%+2.2 pt vs Q2 2024
Net margin15.1%+3.7 pt vs Q2 2024
ended Oct 25, 2024 · filed Nov 26, 2024 · 32 d after period end